PMC:7264098 / 1069-1371 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T24","span":{"begin":0,"end":5},"obj":"NCBITaxon:10239"},{"id":"T25","span":{"begin":17,"end":25},"obj":"SP_7"},{"id":"T26","span":{"begin":42,"end":53},"obj":"UBERON:0003104;CL:0000134"},{"id":"T27","span":{"begin":54,"end":64},"obj":"CL:0000034"},{"id":"T28","span":{"begin":66,"end":70},"obj":"DG_47"},{"id":"T29","span":{"begin":82,"end":90},"obj":"GO:0046903"},{"id":"T30","span":{"begin":262,"end":277},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T85152","span":{"begin":0,"end":5},"obj":"NCBITaxon:10239"},{"id":"T26206","span":{"begin":17,"end":25},"obj":"SP_7"},{"id":"T50420","span":{"begin":42,"end":53},"obj":"UBERON:0003104;CL:0000134"},{"id":"T65832","span":{"begin":54,"end":64},"obj":"CL:0000034"},{"id":"T45368","span":{"begin":66,"end":70},"obj":"DG_47"},{"id":"T88437","span":{"begin":82,"end":90},"obj":"GO:0046903"},{"id":"T5958","span":{"begin":262,"end":277},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"virus leading to COVID-19 disease and how mesenchymal stem cells (MSCs) and their secreted EVs can be utilized to tackle this damage by harnessing their regenerative properties, which gives them potential enhanced clinical utility compared to other investigated pharmacological treatments. There are cu"}

{"project":"LitCovid-PubTator","denotations":[{"id":"29","span":{"begin":17,"end":25},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"virus leading to COVID-19 disease and how mesenchymal stem cells (MSCs) and their secreted EVs can be utilized to tackle this damage by harnessing their regenerative properties, which gives them potential enhanced clinical utility compared to other investigated pharmacological treatments. There are cu"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T14","span":{"begin":42,"end":64},"obj":"Body_part"},{"id":"T15","span":{"begin":59,"end":64},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma0326143"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"virus leading to COVID-19 disease and how mesenchymal stem cells (MSCs) and their secreted EVs can be utilized to tackle this damage by harnessing their regenerative properties, which gives them potential enhanced clinical utility compared to other investigated pharmacological treatments. There are cu"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":17,"end":25},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"virus leading to COVID-19 disease and how mesenchymal stem cells (MSCs) and their secreted EVs can be utilized to tackle this damage by harnessing their regenerative properties, which gives them potential enhanced clinical utility compared to other investigated pharmacological treatments. There are cu"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":0,"end":5},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T15","span":{"begin":42,"end":64},"obj":"http://purl.obolibrary.org/obo/CL_0000134"}],"text":"virus leading to COVID-19 disease and how mesenchymal stem cells (MSCs) and their secreted EVs can be utilized to tackle this damage by harnessing their regenerative properties, which gives them potential enhanced clinical utility compared to other investigated pharmacological treatments. There are cu"}